alexa Aims and Scope - Reports in Disease Markers

Reports in Disease Markers
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Aims and Scope

 » Reports in Disease Markers is a broad-based journal found on two key tenets: To publish the most exciting Reviews on biomarkers: Second to provide a rapid turn-around time possible for reviewing and publishing of articles freely for research, teaching and reference purposes.

 »

It is basically aimed at the Clinical Practitioners, medical/ health practitioners, students, professionals and researchers and professional bodies and institutions.

 »

All works published by OMICS Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Reports in Disease Markers strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. The journal will keep up-to- date reviews on disease biomarkers. Abstracts and full texts (HTML, PDF and XML format) of all articles published by this journal are freely accessible to everyone immediately after publication. Reports in Disease Markers supports the Bethesda Statement on Open Access Publishing.

 »

All published articles will be assigned DOI provided by CrossRef. Reports in Disease Markers will keep upto date with latest advances in the field and papers published in Reports in Disease Markers will reach the readers directly by email for free of cost.

 »

Distributed widely through the Internet.

 »

Archived online in the transactions of the OMICS Group, which provides the international scientific community with immediate and permanent access to individual papers.

 »

Reports in Disease Markers accepts online letters to the editors, brief comments that contributes to the previously published articles or other relevant findings in OMICS field.

 »

Open Access is a publication model, that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under Open Access can be accessed by anyone with internet connection. Reports in Disease Markers strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Reports in Disease Markers are freely accessible to everyone immediately after publication.

 »

All works published by OMICS Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Reports in Disease Markers supports the Bethesda Statement on Open Access Publishing.

Definition of Open Access Publication

 »

An Open Access Publication is one that meets the following two conditions:
 
  • The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.

  • A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).
 »
As a member of Publisher International linking Association, PILA, Reports in Disease Markers (of OMICS Publishing Group) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.

Note:

 »

Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.

 

Top